Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01340599 · ClinicalTrials.gov registry record · Phase 2
Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing Surgery
A Phase 2 study, sponsored by Case Comprehensive Cancer Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT01340599 is a Phase 2 study that was terminated before completion, run by Case Comprehensive Cancer Center. The registered enrollment target is 5 participants.
The verdict
NCT01340599, a Phase 2 study, was terminated before completion, sponsored by Case Comprehensive Cancer Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
This randomized pilot phase II trial studies the side effects and how well defined green tea catechin extract works in treating patients with localized prostate cancer undergoing surgery. Defined green tea catechin extract contains ingredients that may prevent or slow the growth of certain cancers.
Interventions
- OTHER placebo
- OTHER questionnaire administration
- OTHER immunohistochemistry staining method
- OTHER immunoenzyme technique
- DIETARY_SUPPLEMENT defined green tea catechin extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2006-10 |
| Est. Completion | 2007-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01340599
The ClinicalTrials.gov registry entry for NCT01340599 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which placebo is the first listed.
NCT01340599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01340599 about?
NCT01340599 is a clinical study titled "Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing Surgery". This randomized pilot phase II trial studies the side effects and how well defined green tea catechin extract works in treating patients with localized prostate cancer undergoing surgery. Defined green tea catechin extract contains ingredients that may prevent or slow the growth of certain cancers.
What is the current status of trial NCT01340599?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2006-10. Estimated completion is 2007-04.
What interventions are being tested in trial NCT01340599?
The interventions under investigation include: placebo (OTHER), questionnaire administration (OTHER), immunohistochemistry staining method (OTHER), immunoenzyme technique (OTHER), defined green tea catechin extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01340599?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.